Literature DB >> 7949373

Involvement of CYP2D6, CYP3A4, and other cytochrome P-450 isozymes in N-dealkylation reactions.

R T Coutts1, P Su, G B Baker.   

Abstract

Metabolic N-dealkylation is a commonly observed biotransformation with tertiary and secondary amine drugs and related N-alkylated amides, but surprisingly little is known about the cytochrome P-450 isozymes involved in these dealkylation reactions. In this review, evidence is provided that supports the involvement of various P-450 isozymes, but especially CYP3A4 and other isozymes of the CYP3A subfamily. Although CYP2D6 is generally not considered to be capable of catalyzing the N-dealkylation of basic drugs, some examples of the involvement of this important isozyme in N-dealkylation reactions are identified. Procedures used to identify individual P-450 isozymes involved in N-dealkylation reactions are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7949373     DOI: 10.1016/1056-8719(94)90001-9

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  9 in total

Review 1.  Neurochemical and metabolic aspects of antidepressants: an overview.

Authors:  G B Baker; R T Coutts; A J Greenshaw
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

Review 2.  Polymorphic cytochromes P450 and drugs used in psychiatry.

Authors:  R T Coutts; L J Urichuk
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

3.  Metabolism of 9-(2-chlorobenzyl)-, 9-(2-methylbenzyl)- and 9-(2-methoxybenzyl)-adenines by hamster hepatic microsomes.

Authors:  D Y Liu; Z D Liu; K el-Ghomari; J W Gorrod
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Oct-Dec       Impact factor: 2.441

4.  Monitoring cytochrome P-450 activity during rabeprazole treatment in patients with gastresophageal reflux disease.

Authors:  Edoardo G Giannini; Vincenzo Savarino; Roberto Testa
Journal:  Dig Dis Sci       Date:  2006-08-22       Impact factor: 3.199

5.  Lack of interaction of milnacipran with the cytochrome p450 isoenzymes frequently involved in the metabolism of antidepressants.

Authors:  Christian Puozzo; Simone Lens; Christian Reh; Karl Michaelis; Dominique Rosillon; Xavier Deroubaix; Dominique Deprez
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 6.  N-Dealkylation of Amines.

Authors:  Ali Alipour Najmi; Rainer Bischoff; Hjalmar P Permentier
Journal:  Molecules       Date:  2022-05-20       Impact factor: 4.927

7.  Molecular Determinants of Substrate Affinity and Enzyme Activity of a Cytochrome P450BM3 Variant.

Authors:  Inacrist Geronimo; Catherine A Denning; David K Heidary; Edith C Glazer; Christina M Payne
Journal:  Biophys J       Date:  2018-08-27       Impact factor: 4.033

Review 8.  The contribution of single-cell analysis of acute leukemia in the therapeutic strategy.

Authors:  Lamia Madaci; Julien Colle; Geoffroy Venton; Laure Farnault; Béatrice Loriod; Régis Costello
Journal:  Biomark Res       Date:  2021-06-27

9.  Alteration of drug metabolizing enzymes in sulphite oxidase deficiency.

Authors:  Begum Tutuncu; Vural Kuçukatay; Sevki Arslan; Barbaros Sahin; Asli Semiz; Alaattin Sen
Journal:  J Clin Biochem Nutr       Date:  2012-03-30       Impact factor: 3.114

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.